Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 16 studies | 35% ± 14% | |
oligodendrocyte precursor cell | 14 studies | 58% ± 20% | |
microglial cell | 12 studies | 31% ± 11% | |
fibroblast | 10 studies | 35% ± 10% | |
endothelial cell | 8 studies | 33% ± 13% | |
glutamatergic neuron | 6 studies | 36% ± 15% | |
macrophage | 6 studies | 31% ± 12% | |
B cell | 6 studies | 26% ± 6% | |
pericyte | 5 studies | 35% ± 15% | |
type I pneumocyte | 5 studies | 20% ± 2% | |
type II pneumocyte | 5 studies | 35% ± 4% | |
GABAergic neuron | 4 studies | 35% ± 7% | |
epithelial cell | 4 studies | 19% ± 3% | |
neuron | 4 studies | 25% ± 11% | |
dendritic cell | 4 studies | 21% ± 4% | |
Mueller cell | 4 studies | 43% ± 10% | |
myeloid cell | 4 studies | 27% ± 12% | |
smooth muscle cell | 4 studies | 30% ± 14% | |
basal cell | 4 studies | 32% ± 13% | |
connective tissue cell | 3 studies | 28% ± 2% | |
T cell | 3 studies | 19% ± 3% | |
alveolar macrophage | 3 studies | 20% ± 3% | |
monocyte | 3 studies | 20% ± 1% | |
lymphocyte | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 1346.76 | 2617 / 2642 | 100% | 63.72 | 704 / 705 |
thymus | 100% | 4346.89 | 652 / 653 | 99% | 46.04 | 596 / 605 |
prostate | 100% | 1067.60 | 244 / 245 | 80% | 7.97 | 402 / 502 |
skin | 100% | 1441.34 | 1804 / 1809 | 78% | 9.02 | 368 / 472 |
pancreas | 99% | 1481.50 | 325 / 328 | 78% | 7.33 | 138 / 178 |
lung | 99% | 1124.29 | 575 / 578 | 71% | 11.73 | 821 / 1155 |
esophagus | 98% | 1276.31 | 1421 / 1445 | 72% | 10.97 | 131 / 183 |
uterus | 100% | 1404.64 | 170 / 170 | 70% | 8.64 | 320 / 459 |
breast | 99% | 1281.01 | 456 / 459 | 61% | 6.28 | 686 / 1118 |
bladder | 100% | 1856.00 | 21 / 21 | 58% | 8.07 | 292 / 504 |
adrenal gland | 100% | 1842.24 | 258 / 258 | 43% | 13.28 | 100 / 230 |
ovary | 100% | 1764.52 | 180 / 180 | 40% | 3.28 | 172 / 430 |
intestine | 94% | 1474.25 | 904 / 966 | 24% | 2.35 | 124 / 527 |
stomach | 77% | 866.49 | 277 / 359 | 30% | 3.52 | 85 / 286 |
kidney | 72% | 456.93 | 64 / 89 | 29% | 3.68 | 260 / 901 |
spleen | 100% | 1016.67 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.73 | 1 / 1 |
blood vessel | 99% | 1428.58 | 1327 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 1283.46 | 1191 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 8.14 | 35 / 45 |
heart | 67% | 409.39 | 574 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 59% | 4.74 | 47 / 80 |
lymph node | 0% | 0 | 0 / 0 | 41% | 3.32 | 12 / 29 |
muscle | 25% | 100.83 | 204 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 20% | 274.07 | 182 / 929 | 0% | 0 | 0 / 0 |
liver | 3% | 11.48 | 7 / 226 | 10% | 2.02 | 42 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030010 | Biological process | establishment of cell polarity |
GO_0030208 | Biological process | dermatan sulfate biosynthetic process |
GO_0006477 | Biological process | protein sulfation |
GO_0050770 | Biological process | regulation of axonogenesis |
GO_0000139 | Cellular component | Golgi membrane |
GO_0016020 | Cellular component | membrane |
GO_0008146 | Molecular function | sulfotransferase activity |
Gene name | UST |
Protein name | Uronyl 2-sulfotransferase (EC 2.8.2.-) |
Synonyms | DS2ST |
Description | FUNCTION: Sulfotransferase that catalyzes the transfer of sulfate to the position 2 of uronyl residues. Has mainly activity toward iduronyl residues in dermatan sulfate, and weaker activity toward glucuronyl residues of chondroitin sulfate. Has no activity toward desulfated N-resulfated heparin. |
Accessions | ENST00000367463.5 Q9Y2C2 |